Metronidazole Dosing for 1-Year-Old
For a 1-year-old child, metronidazole should be dosed at 7.5 mg/kg per dose given 3-4 times daily (maximum 500 mg per dose) for most indications, with the specific frequency and indication determining the exact regimen.
Dosing by Indication
For C. difficile Infection (Non-severe)
- Dose: 7.5 mg/kg per dose
- Frequency: Three or four times daily (TID or QID)
- Maximum: 500 mg per dose
- Duration: 10 days
- Route: Oral 1
This represents the standard pediatric dosing from the 2018 IDSA/SHEA guidelines for non-severe CDI in children.
For Anaerobic Infections (General)
- Dose: 30-40 mg/kg/day divided into doses
- IV dosing: 30 mg/kg/day divided
- Oral dosing: 40-50 mg/kg/day divided
- Frequency: Typically divided into 3-4 doses daily 2
Research supports that children aged 4 weeks to 14 years achieve similar pharmacokinetic parameters to adults when given weight-based dosing around 10-20 mg/kg twice daily 3.
Critical Age-Related Considerations
Important caveat: A 1-year-old child (12 months) has significantly different pharmacokinetics than younger infants. The elimination half-life of metronidazole is:
- Under 8 weeks of age: 18.4 hours (prolonged)
- Over 8 weeks of age: 7 hours (similar to adults) 4
Since your patient is 1 year old, they should have adult-like clearance and do not require the extended dosing intervals needed for very young infants.
Practical Dosing Example
For a typical 1-year-old weighing 10 kg:
- 7.5 mg/kg/dose = 75 mg per dose
- Given TID = 225 mg/day total
- Given QID = 300 mg/day total
Both regimens are well below the maximum daily dose and achieve therapeutic concentrations.
Safety Monitoring
The FDA label notes that safety and effectiveness in pediatric patients have not been formally established except for amebiasis 5. However, extensive clinical experience supports its use in children for anaerobic infections with appropriate dosing.
Key safety points:
- Monitor for neurological adverse effects with prolonged therapy
- Metronidazole crosses into CSF and achieves bactericidal concentrations 5
- Peak plasma concentrations occur 1-2 hours after oral administration 5
- Recent data from the SCAMP trial in infants showed that higher exposures correlated with therapeutic success without increased safety events 6
Special Circumstances
Malnourished children: Require dose reduction due to prolonged half-life (10.2 hours vs 5.1 hours) and reduced metabolic clearance 7. This is critical to avoid toxicity.
Severe/fulminant CDI: Switch to vancomycin as metronidazole is not recommended for severe disease in children 1.